Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer.

Vlachostergios PJ, Karasavvidou F, Kakkas G, Kapatou K, Gioulbasanis I, Daliani DD, Moutzouris G, Papandreou CN.

J Negat Results Biomed. 2012 Jan 5;11(1):2. doi: 10.1186/1477-5751-11-2.

2.

Low p27 expression predicts poor disease-free survival in patients with prostate cancer.

Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE.

J Urol. 1998 Mar;159(3):941-5.

PMID:
9474188
3.

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

Revelos K, Petraki C, Gregorakis A, Scorilas A, Papanastasiou P, Tenta R, Koutsilieris M.

In Vivo. 2005 Sep-Oct;19(5):911-20.

4.

Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.

Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH.

J Urol. 2000 Dec;164(6):2156-61.

PMID:
11061947
5.

Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.

Thomas GV, Schrage MI, Rosenfelt L, Kim JH, Salur G, deKernion JB, Dorey F, Said J, Reiter RE.

J Urol. 2000 Dec;164(6):1987-91.

PMID:
11061897
6.

Low p27 expression predicts biochemical relapse after radical prostatectomy in patients with clinically localised prostate cancer.

Ribal MJ, Fernandez PL, Lopez-Guillermo A, Farré X, Santos Y, Gibanel R, Cardesa A, Alcaraz A.

Anticancer Res. 2003 Nov-Dec;23(6D):5101-6.

PMID:
14981973
7.

Expression of p21 cell cycle protein is an independent predictor of response to salvage radiotherapy after radical prostatectomy.

Rigaud J, Tiguert R, Decobert M, Hovington H, Latulippe E, Laverdiere J, Larue H, Lacombe L, Fradet Y.

Prostate. 2004 Feb 15;58(3):269-76.

PMID:
14743466
8.

Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression.

Freedland SJ, de Gregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Elashoff DA, Reiter RE, Aronson WJ.

Urology. 2003 Jun;61(6):1187-92.

PMID:
12809895
9.

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.

Lee CT, Capodieci P, Osman I, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C.

Clin Cancer Res. 1999 May;5(5):977-83.

11.

Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients.

Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL.

Clin Cancer Res. 2001 Mar;7(3):544-50.

12.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

13.

Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.

Georgiadou D, Sergentanis TN, Sakellariou S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, Psaltopoulou T, Lazaris AC, Patsouris E, Zografos GC.

APMIS. 2014 Dec;122(12):1230-9. doi: 10.1111/apm.12289. Epub 2014 Jul 22.

PMID:
25053516
14.

Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.

Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ.

J Urol. 2003 Apr;169(4):1325-30.

PMID:
12629353
15.

The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy.

Nguyen PL, Lin DI, Lei J, Fiorentino M, Mueller E, Weinstein MH, Pagano M, Loda M.

Urol Oncol. 2011 May-Jun;29(3):302-8. doi: 10.1016/j.urolonc.2009.03.022. Epub 2009 May 17.

16.

The value of EZH2, p27(kip1), BMI-1 and MIB-1 on biopsy specimens with low-risk prostate cancer in selecting men with significant prostate cancer at prostatectomy.

Wolters T, Vissers KJ, Bangma CH, Schröder FH, van Leenders GJ.

BJU Int. 2010 Jul;106(2):280-6. doi: 10.1111/j.1464-410X.2009.08998.x. Epub 2009 Nov 3.

17.

Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.

Zhou M, Hayasaka S, Taylor JM, Shah R, Proverbs-Singh T, Manley S, Rubin MA.

J Urol. 2001 Dec;166(6):2193-7.

PMID:
11696734
18.

Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer.

Vis AN, van Rhijn BW, Noordzij MA, Schröder FH, van der Kwast TH.

J Pathol. 2002 Jun;197(2):148-54.

PMID:
12015737
19.

Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.

Halvorsen OJ, Høstmark J, Haukaas S, Høisaeter PA, Akslen LA.

Cancer. 2000 Jan 15;88(2):416-24.

PMID:
10640976
20.

Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.

Freedland SJ, Presti JC Jr, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL; SEARCH Database Study Group.

J Urol. 2003 Jun;169(6):2129-35.

PMID:
12771734

Supplemental Content

Support Center